NCT07649057Recruiting
A Study of a Urine Test to Detect Colorectal Cancer
Memorial Sloan Kettering Cancer Center
Start Date
6/11/2026
Completion Date
6/11/2028
Summary
The purpose of this study is to find out whether a urine test can detect colorectal cancer (CRC) and precancerous polyps in participants living in Ghana, Tanzania, and South Africa.
Eligibility Criteria
Age Range: 18 years to No maximum
Inclusion Criteria:
* Patient presents with one of the following:
* Patients with symptoms of CRC (such as rectal bleeding for a week) -OR-
* Patients who present for a screening colonoscopy -OR-
* Has received one of the following within 3 weeks of the planned urine collection
* Patients with a pathologic diagnosis of CRC either by colonoscopy or resection specimens -OR-
* Patients with colonoscopy demonstrating adenomatous polyps -OR-
* Patients with colonoscopy demonstrating no colon or premalignant or malignant pathology
* Age ≥ 18
* Willingness to participate in the study
Interventions
DIAGNOSTIC_TEST
3-metabolite biosensor
Conditions
Colorectal CancerPrecancerous PolypRectal BleedingCRC
Locations
Memorial Sloan Kettering Cancer Center (All Protocol Activities)
New York, New York 10065
United States
Korle Bu Teaching Hospital (Data Collection Only)
Accra,
Ghana
Wits Donald Gordon Medical Centre (Data Collection Only)
Johannesburg,
South Africa
Kilimanjaro Christian Medical Centre (Data Collection Only)
Moshi,
Tanzania